MGP Ingredients Inc (CASK) stock
Close on Nov 5, 2026Market cap $375.28MP/E –Yield 2.74%
Earnings
MGP Ingredients's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of MGP Ingredients's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Feb 24, 2027Expected | – | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Oct 28, 2026before the open | $117.90M | -9.9% | $0.32 | $0.39 | Release |
| Q2 FY2026ended Jun 30, 2026 | Jul 29, 2026before the open | $124.40M | -14.5% | $0.55 | $0.72 | Release |
| Q1 FY2026ended Mar 31, 2026 | Apr 29, 2026before the open | $106.40M | -12.6% | -$6.30 | $0.15 | Release |
| Q4 FY2025ended Dec 31, 2025 | Feb 25, 2026before the open | $138.30M | -23.5% | – | $0.63 | Release |
| Q3 FY2025ended Sep 30, 2025 | Oct 29, 2025before the open | $130.90M | -18.9% | $0.71 | $0.85 | Release |
| Q2 FY2025ended Jun 30, 2025 | Jul 31, 2025before the open | $145.50M | -23.7% | $0.67 | $0.97 | Release |
| Q1 FY2025ended Mar 31, 2025 | May 1, 2025before the open | $121.70M | -28.7% | -$0.14 | $0.36 | Release |
| Q4 FY2024ended Dec 31, 2024 | Feb 26, 2025before the open | $180.80M | -15.9% | – | $1.57 | Release |
| Q3 FY2024ended Sep 30, 2024 | Oct 31, 2024before the open | $161.50M | -23.7% | $1.07 | $1.29 | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 1, 2024before the open | $190.80M | -8.7% | $1.43 | $1.71 | Release |
| Q1 FY2024ended Mar 31, 2024 | May 2, 2024before the open | $170.60M | -15.1% | $0.92 | $1.07 | Release |
| Q4 FY2023ended Dec 31, 2023 | Feb 22, 2024before the open | $214.90M | +12.5% | $1.39 | $1.64 | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 2, 2023before the open | $211.60M | +5.2% | $0.58 | $1.34 | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 3, 2023before the open | $209.00M | +7.2% | $1.44 | $1.49 | Release |
| Q1 FY2023ended Mar 31, 2023 | May 4, 2023before the open | $201.00M | +3.0% | $1.39 | – | Release |
| Q4 FY2022ended Dec 31, 2022 | Feb 23, 2023before the open | $191.00M | +14.5% | $1.01 | $1.01 | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 3, 2022before the open | $201.20M | +13.9% | $1.06 | $1.06 | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 4, 2022before the open | $195.00M | – | $1.15 | $1.15 | Release |
| Q1 FY2022ended Mar 31, 2022 | May 5, 2022before the open | $195.20M | – | $1.69 | $1.69 | Release |
| Q4 FY2021ended Dec 31, 2021 | Feb 24, 2022before the open | $166.80M | – | $1.40 | $0.87 | Release |
| Q3 FY2021ended Sep 30, 2021 | Nov 3, 2021before the open | $176.60M | – | $1.08 | $1.09 | Release |
| Q2 FY2021ended Jun 30, 2021 | Aug 4, 2021before the open | – | – | – | – | Release |
| Q1 FY2021ended Mar 31, 2021 | May 5, 2021before the open | – | – | – | – | Release |
| Q4 FY2020ended Dec 31, 2020 | Feb 25, 2021before the open | – | – | – | – | Release |
| Q3 FY2020ended Sep 30, 2020 | Oct 29, 2020before the open | – | – | – | – | Release |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
MGP Ingredients's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| SalesGAAP | FY2026 | $480.00M – $500.00M | – | New | Oct 28, 2026 |
| Sales | FY2026 | $480.00M – $500.00M | $480.00M – $500.00M | Reaffirmed | Jul 29, 2026 |
| Adjusted EBITDAnon-GAAP | FY2026 | $90.00M – $98.00M | – | New | Oct 28, 2026 |
| Adjusted EBITDAnon-GAAP | FY2026 | $90.00M – $98.00M | $90.00M – $98.00M | Reaffirmed | Jul 29, 2026 |
| Adjusted basic EPSnon-GAAP | FY2026 | $1.50 – $1.80 | – | New | Oct 28, 2026 |
| Adjusted basic EPSnon-GAAP | FY2026 | $1.50 – $1.80 | $1.50 – $1.80 | Reaffirmed | Jul 29, 2026 |
| capital expendituresGAAP | FY2026 | $20.00M | – | New | Oct 28, 2026 |
| Full-year capital expenditures | FY2026 | $20.00M | $20.00M | Reaffirmed | Jul 29, 2026 |
| effective tax rateGAAP | FY2026 | 23% | – | New | Oct 28, 2026 |
| effective tax rate | FY2026 | 23% | 27% | Lowered | Jul 29, 2026 |
| weighted average basic shares outstandingGAAP | FY2026 | 21.4 | – | New | Oct 28, 2026 |
Guidance vs results
The last range MGP Ingredients gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| FY2025 | Adjusted basic EPS | $2.60 – $2.75 | $2.81Σ4Q | Above range |
| FY2025 | Revenue | $525.00M – $535.00M | $536.40MΣ4Q | Above range |
Guidance history
Every forecast MGP Ingredients put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Oct 28, 2026 | capital expenditures | FY2026 | $20.00M | New |
| Oct 28, 2026 | Adjusted EBITDA | FY2026 | $90.00M – $98.00M | New |
| Oct 28, 2026 | Adjusted basic EPS | FY2026 | $1.50 – $1.80 | New |
| Oct 28, 2026 | weighted average basic shares outstanding | FY2026 | 21.4 | New |
| Oct 28, 2026 | effective tax rate | FY2026 | 23% | New |
| Oct 28, 2026 | Sales | FY2026 | $480.00M – $500.00M | New |
| Jul 29, 2026 | Full-year capital expenditures | FY2026 | $20.00M | Reaffirmed |
| Jul 29, 2026 | Adjusted EBITDA | FY2026 | $90.00M – $98.00M | Reaffirmed |
| Jul 29, 2026 | Adjusted basic EPS | FY2026 | $1.50 – $1.80 | Reaffirmed |
| Jul 29, 2026 | effective tax rate | FY2026 | 23% | Lowered |
| Jul 29, 2026 | Sales | FY2026 | $480.00M – $500.00M | Reaffirmed |
| Apr 29, 2026 | capital expenditures | FY2026 | $20.00M | Reaffirmed |
| Apr 29, 2026 | Adjusted EBITDA | FY2026 | $90.00M – $98.00M | Reaffirmed |
| Apr 29, 2026 | Adjusted basic EPS | FY2026 | $1.50 – $1.80 | Reaffirmed |
| Apr 29, 2026 | effective tax rate | FY2026 | 27% | New |
| Apr 29, 2026 | Sales | FY2026 | $480.00M – $500.00M | Reaffirmed |
| Feb 25, 2026 | capital expenditures | FY2026 | $20.00M | New |
| Feb 25, 2026 | Adjusted EBITDA | FY2026 | $90.00M – $98.00M | New |
| Feb 25, 2026 | Adjusted basic EPS | FY2026 | $1.50 – $1.80 | New |
| Feb 25, 2026 | Sales | FY2026 | $480.00M – $500.00M | New |
| Oct 29, 2025 | Adjusted EBITDA | FY2025 | $110.00M – $115.00M | New |
| Oct 29, 2025 | Adjusted basic EPS | FY2025 | $2.60 – $2.75 | New |
| Oct 29, 2025 | Sales | FY2025 | $525.00M – $535.00M | New |
| Jul 31, 2025 | Full-year capital expenditures | FY2025 | $32.50M | Lowered |
| Jul 31, 2025 | Adjusted EBITDA | FY2025 | $105.00M – $115.00M | Reaffirmed |
| Jul 31, 2025 | Adjusted basic EPS | FY2025 | $2.45 – $2.75 | Reaffirmed |
| Jul 31, 2025 | Sales | FY2025 | $520.00M – $540.00M | Reaffirmed |
| May 1, 2025 | capital expenditures | FY2025 | $36.00M | Reaffirmed |
| May 1, 2025 | Adjusted EBITDA | FY2025 | $105.00M – $115.00M | Reaffirmed |
| May 1, 2025 | Adjusted basic EPS | FY2025 | $2.45 – $2.75 | Reaffirmed |
| May 1, 2025 | Sales | FY2025 | $520.00M – $540.00M | Reaffirmed |
| Feb 26, 2025 | capital expenditures | FY2025 | $36.00M | New |
| Feb 26, 2025 | Adjusted EBITDA | FY2025 | $105.00M – $115.00M | New |
| Feb 26, 2025 | Adjusted basic EPS | FY2025 | $2.45 – $2.75 | New |
| Feb 26, 2025 | Sales | FY2025 | $520.00M – $540.00M | New |
| Oct 31, 2024 | capital expenditures | FY2024 | $78.00M | Reaffirmed |
| Oct 31, 2024 | Adjusted EBITDA | FY2024 | $196.00M – $200.00M | Reaffirmed |
| Oct 31, 2024 | Adjusted basic EPS | FY2024 | $5.55 – $5.65 | Reaffirmed |
| Oct 31, 2024 | Sales | FY2024 | $695.00M – $705.00M | Lowered |
| Oct 17, 2024 | Capital expenditures | FY2024 | $78.00M | New |
| Oct 17, 2024 | adjusted EBITDA | FY2024 | $196.00M – $200.00M | Lowered |
| Oct 17, 2024 | adjusted basis EPS | FY2024 | $5.55 – $5.65 | Lowered |
| Oct 17, 2024 | Basic weighted average shares outstanding | FY2024 | 22.1 | Lowered |
| Oct 17, 2024 | Effective tax rate | FY2024 | 24% | New |
| Oct 17, 2024 | sales | FY2024 | $695.00M – $705.00M | New |
| Aug 1, 2024 | capital expenditures | FY2024 | $85.00M | New |
| Aug 1, 2024 | Adjusted EBITDA | FY2024 | $218.00M – $222.00M | Reaffirmed |
| Aug 1, 2024 | Adjusted basic earnings per common share | FY2024 | $6.12 – $6.23 | Reaffirmed |
| Aug 1, 2024 | basic weighted average shares outstanding | FY2024 | 22.3 | New |
| Aug 1, 2024 | Sales | FY2024 | $742.00M – $756.00M | Reaffirmed |
| May 2, 2024 | Adjusted EBITDA | FY2024 | $218.00M – $222.00M | Raised |
| May 2, 2024 | Adjusted basic earnings per common share | FY2024 | $6.12 – $6.23 | Reaffirmed |
| May 2, 2024 | basic weighted average shares outstanding | FY2024 | 22.3 | New |
| May 2, 2024 | Sales | FY2024 | $742.00M – $756.00M | Reaffirmed |
| Feb 22, 2024 | Adjusted EBITDA | FY2024 | $213.00M – $217.00M | New |
| Feb 22, 2024 | Adjusted basic earnings per common share | FY2024 | $6.12 – $6.23 | New |
| Feb 22, 2024 | Sales | FY2024 | $742.00M – $756.00M | New |
| Nov 2, 2023 | Adjusted EBITDA | FY2023 | $192.00M – $197.00M | Raised |
| Nov 2, 2023 | Adjusted basic EPS | FY2023 | $5.50 – $5.65 | Raised |
| Nov 2, 2023 | Sales | FY2023 | $815.00M – $835.00M | Reaffirmed |
| Aug 3, 2023 | Adjusted EBITDA | FY2023 | $187.00M – $192.00M | Raised |
| Aug 3, 2023 | Adjusted basic EPS | FY2023 | $5.35 – $5.50 | Raised |
| Aug 3, 2023 | Sales | FY2023 | $815.00M – $835.00M | Reaffirmed |
| May 4, 2023 | Adjusted EBITDA | FY2023 | $178.00M – $183.00M | Reaffirmed |
| May 4, 2023 | Adjusted basic EPS | FY2023 | $5.05 – $5.20 | Reaffirmed |
| May 4, 2023 | Sales | FY2023 | $815.00M – $835.00M | Reaffirmed |
| Feb 23, 2023 | Adjusted EBITDA | FY2023 | $178.00M – $183.00M | New |
| Feb 23, 2023 | Adjusted basic earnings per common share | FY2023 | $5.05 – $5.20 | New |
| Feb 23, 2023 | Sales | FY2023 | $815.00M – $835.00M | New |
| Nov 3, 2022 | Adjusted EBITDA | FY2022 | $162.00M – $167.00M | Raised |
| Nov 3, 2022 | Adjusted basic earnings per common share | FY2022 | $4.62 – $4.80 | Raised |
| Nov 3, 2022 | Sales | FY2022 | $765.00M – $780.00M | Raised |
| Aug 4, 2022 | Adjusted EBITDA | FY2022 | $156.00M – $163.00M | Raised |
| Aug 4, 2022 | Basic adjusted earnings per common share | FY2022 | $4.41 – $4.65 | Raised |
| Aug 4, 2022 | Sales | FY2022 | $745.00M – $765.00M | Raised |
| May 5, 2022 | Adjusted EBITDA | FY2022 | $150.00M – $157.00M | Reaffirmed |
| May 5, 2022 | Basic adjusted earnings per share | FY2022 | $4.15 – $4.35 | Raised |
| May 5, 2022 | Sales | FY2022 | $690.00M – $715.00M | Reaffirmed |
| Feb 24, 2022 | Adjusted EBITDA | FY2022 | $150.00M – $157.00M | New |
| Feb 24, 2022 | Fully diluted adjusted earnings per share | FY2022 | $3.95 – $4.10 | New |
| Feb 24, 2022 | Sales | FY2022 | $690.00M – $715.00M | New |
| Nov 3, 2021 | Adjusted EBITDA | FY2021 | $125.00M – $135.00M | New |
| Nov 3, 2021 | Adjusted earnings per share | FY2021 | $3.75 – $4.05 | New |
| Nov 3, 2021 | Sales | FY2021 | $570.00M – $615.00M | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases MGP Ingredients filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Update
- Results
- Results
- Update
- Results
- Results
- Results
- Update
- Update
- Results
- Results
- Results
- Results
- Results
See a number that looks wrong?